At CD Genomics, our highly sensitive assays seamlessly integrate tumor-and-normal profiling with proprietary algorithms, delivering advanced insights that evolve with the ever-changing nature of diseases. Our services span across critical areas such as immuno-oncology, biomarker discovery, gene editing, and cell projects. We empower biopharma and researchers to make informed decisions by enabling the selection of targeted therapies through ultra-comprehensive genomic profiling. This not only enhances therapeutic outcomes but also plays a pivotal role in refining biomarker strategies for drug development.
CD Genomics plays a pivotal role in refining biomarker strategies for drug development.
